GenomeWeb: Cynvenio Looks to Add Cell-free DNA Analysis to Circulating Tumor Cell Platform

Sept. 10, 2014 - In this Clinical Sequencing News article published by GenomeWeb, contributing editor Molika Ashford interviews Paul Dempsey, Ph.D., Cynvenio’s Chief Scientific Officer.  Dr. Dempsey discusses the company’s research and activities to establish the utility of cell-free DNA relative to, and potentially in combination with CTC analysis.  [Premium Subscriber Content]


[ Back to News Page ]